Clicky

Seres Therapeutics, Inc.(MCRB) News

Date Title
Oct 8 Institutions along with retail investors who hold considerable shares inSeres Therapeutics, Inc. (NASDAQ:MCRB) come under pressure; lose 12% of holdings value
Sep 30 Seres Therapeutics Announces Completion of VOWST™ Asset Sale to Société des Produits Nestlé S.A
Sep 26 Seres Therapeutics Stockholders Approve Sale of VOWST™ to Nestlé Health Science; Sale Expected to Close on September 30
May 13 Seres Therapeutics, Inc. (NASDAQ:MCRB) Q1 2024 Earnings Call Transcript
May 9 Seres Therapeutics First Quarter 2024 Earnings: US$0.28 loss per share (vs US$0.56 loss in 1Q 2023)
May 9 Seres Therapeutics Inc (MCRB) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights ...
May 8 Seres Therapeutics Reports Q1 2024 Earnings: Surpasses Revenue Estimates
May 8 Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
May 6 Seres Therapeutics to Announce First Quarter 2024 Financial Results and Business Update on May 8, 2024
Apr 9 Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
Mar 28 Increases to Seres Therapeutics, Inc.'s (NASDAQ:MCRB) CEO Compensation Might Cool off for now
Mar 19 Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 13 11 Oversold NASDAQ Stocks To Buy Right Now
Mar 13 11 Oversold Healthcare Stocks To Buy Right Now
Mar 7 Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2023 Earnings Call Transcript
Mar 6 Q4 2023 Seres Therapeutics Inc Earnings Call
Mar 5 Seres Therapeutics Inc (MCRB) Reports Encouraging Sales Growth and Strategic Cost Savings in 2023
Mar 5 Seres Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
Jan 9 Seres Therapeutics Announces VOWST™ Commercial Launch Update and US FDA Fast Track Designation for SER-155
Jan 4 Seres Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference